Skip to main content
Erschienen in: Multidisciplinary Respiratory Medicine 1/2018

Open Access 01.12.2018 | Original research article

A quick relaxation exercise for people with chronic obstructive pulmonary disease: explorative randomized controlled trial

verfasst von: Eleonora Volpato, Paolo Banfi, Antonello Nicolini, Francesco Pagnini

Erschienen in: Multidisciplinary Respiratory Medicine | Ausgabe 1/2018

Abstract

Background

People with Chronic Obstructive Pulmonary Disease (COPD) suffer from dyspnoea, which may be increased by anxiety. Previous studies suggest that relaxation techniques may have positive effects in pulmonary rehabilitation. The main aim of this study is to explore the clinical impact of a quick, one-session, relaxation training for people with COPD.

Methods

In this perspective, 38 participants with COPD were recruited and randomly assigned to listen to a relaxing audio or to watch a neutral stimulus, during their routine exams. Participants were assessed for psychological and physiological variables, analysed through non-parametric tests.

Results

Those who joined the relaxation training showed more positive outcomes about respiratory and cardiac assessments, as well as for state anxiety and positive affections, in comparison with the baseline and the control group.

Conclusions

Study results suggest that relaxation has a potential to produce improvements in respiratory and cardiac functions, together with a positive emotional effect and a reduction of anxiety.

Trial registration

ClinicalTrials.gov ID: NCT02698904. Record Registration: February 2016.
Abkürzungen
CBT
Cognitive Behavioral Therapy
CG
control group
COPD
Chronic Obstructive Pulmonary Disease
EG
experimental group
FEV1
Forced Expiratory Volume in the First Second
FEV1/FVC
Tiffeneau-Pinelli Index
FVC
Forced Vital Capacity
GOLD
Global Initiative for Chronic Obstructive Lung Disease
NA
negative affect
PA
positive affect
PANAS
Positive and Negative Affective Schedule
RCT
Randomized Control Trial
Short FSS-2
Short Flow State Scale
SPSS
Statistical Package for Social Science
STAI
State-Trait Anxiety Inventory
VAS
Visual Analogue Scales

Background

Chronic Obstructive Pulmonary Disease (COPD) is a complex, debilitating, and preventable lung condition, characterized by "persistent and progressive airflow limitation due to chronic inflammatory response in the airways and the lung to noxious particles or gases" with different degrees of impairment [1]. There is a progressive pulmonary function impairment that leads to a lower exercise tolerance and, in severe conditions, to the need for oxygen and possibly mechanical ventilation [2]. Other main symptoms of COPD include chronic cough, dyspnea, overproduction of sputum, wheezing, chest tightness, asthenia, weight loss, and anorexia [1]. All these symptoms have a negative impact on the quality of life [3, 4]. The prevalence of the diseases is increasing as there is an increasing exposure to risk factors [57]. In fact, it is estimated that COPD may become the third cause of death in the world by 2020 [8]. In this respect, in patients with advanced COPD and severe chronic hypoxemia refractory to maximal treatment with bronchodilator and anti-inflammatory drugs, smoking cessation and long-term oxygen therapy are the only two interventions that have unequivocally shown to reduce COPD mortality [1].
Pulmonary rehabilitation is very important at any stage of the disease, improving the ability to tolerate fatigue and dyspnea, with a beneficial effect on daily activities [912]. People with COPD are at risk of severe distress [13]. Depression and anxiety often appear together in these patients [14], even if the actual presence of psychological issues tends to be underestimated by the physicians [15]. Therefore, these aspects often remain untreated [14, 16, 17], with negative effects on the quality of life [18, 19].
Relaxation techniques are psychophysiological procedures that promote somatic and cognitive distension, relieving from tensions. These techniques are widely used in rehabilitation and are very effective against anxiety and distress [20, 21]. Both the physiological and the psychological effects of relaxation have a positive effect on people affected by pulmonary diseases [22], improving the oxygen saturation [23, 24] and promoting a reduction of anxiety and depression in people with COPD [2527]. The cost-effectiveness of adding this technique to a rehabilitation program, however, is not clear [27, 28]. So far [29], relaxation training for people with COPD has often been tested in the mainframe of more general interventions (e.g., Cognitive Behavioral Therapy - CBT). We believe that a quick relaxation training, provided by an audio-guide right after their hospital exams, will promote positive emotions, reduce state anxiety and improve respiratory conditions. In this perspective, our aim is to investigate the feasibility of the relaxation technique’s application for people with COPD, exploring its preliminary efficacy and effectiveness in a short time of implementation. To date, no study has looked at verifying the experience of a brief relaxation exercise impact breathing and psychological parameters in people with COPD in the context of a clinical visit.

Methods

Study aims

The main aim of this study is to explore the effectiveness, feasibility and acceptability of a quick, one-session, relaxation training for people with Chronic Obstructive Pulmonary Disease (COPD) in a short time of implementation.

Design and setting of the study

We conducted an explorative, two-arms, single-blind Randomized Controlled Trial (RCT) to test the short-term effects of a one-session relaxation training based on mindful natural breathing on people with COPD. Thirty-eight subjects with COPD were recruited from the Respiratory Rehabilitation Unit of the Don Gnocchi Hospital, in Milan. The study was approved by the Don Gnocchi Foundation Ethical Committee. ClinicalTrials.gov ID: NCT02698904.

Participants

Inclusion criteria were defined as follow: diagnosis of COPD confirmed by a specialized physician; age above or equal to 18 years; inpatients or outpatients; basal FEV1/FVC < 70% of reference values, using the standards established by Global Initiative for Chronic Obstructive Lung Disease (GOLD) [1]. Subjects were excluded in case of pregnancy, psychiatric disturbances, oncological diseases and comorbid states that determine an immunosuppressive condition.
Subjects who met the inclusions criteria were randomly allocated to two groups. A simple randomization and an allocation ratio 1:1 were adopted (Fig. 1).
Informed consent was obtained. At baseline assessment, as well as at the end of the intervention (soon after), patients were assessed both about their psychological state (psychometric questionnaires) and their pulmonary function and physiological conditions (spirometry, saturation level and heart rate). While assessed, participants were blinded to their assignment.

Intervention

Subjects in the experimental group (EG) listened to a relaxing audio track of the duration of 11 min. The content of the audio track was a relaxation exercise based on the mindful natural breathing [30]. Instructions included becoming aware of the sensations of breathing, accepting them as they are at the present moment and non-judgmental awareness of mind wandering. Subjects laid down on a rigid but not hard bed, with a pillow, to facilitate muscle release, listening to the audio track with a pair of headphones. Instructions included focusing on the breathing mechanism, by purposefully paying attention to the breath, placing the left hand on the chest and the right on abdomen, improving the perception of torso movements. These exercises aim to increase the awareness of the respiratory process, leading to a relaxation response [31]. Relaxing music was played on the background. Subjects were advised to close their eyes.
Participants in the control group (CG), instead, watched a documentary movie that included neutral contents and the same duration of the relaxation audio, in a relaxing setting similar to the other group.

Instruments

Physiological assessment

We assessed COPD severity with the lung function test, detecting Forced Vital Capacity (FVC), Forced Expiratory Volume in the First Second (FEV1), Tiffeneau-Pinelli Index (FEV1/FVC) with spirometer PONY FX (COSMED Srl, Rome, Italy). We also used the module Rocc Pony FX, which allows the measurement of airway resistance (kPa/l/s) using the technique of interrupter resistance (Rint). Furthermore, we detected the heart rate and oxygen saturation using pulse oximeter, Pulsox 300i (Konica Minolta, Inc.). The criteria used to determine if the spirometry tests were performed to an acceptable degree followed the Thoracic Society/European Respiratory Society Statement [32].

State trait anxiety inventory - Y1 and Y2 forms (STAI- Y1 Y2)

The State-Trait Anxiety Inventory (STAI) is a self-report assessment device which includes separate measures of state and trait anxiety [33].

Positive and negative affective schedule (PANAS) (state version)

The state version of Positive and Negative Affective Schedule (PANAS) was completed before and after treatment. It consists of 20 items, 10 for the scale of positive affect (PA) and 10 for the scale of negative affect (NA). The subject should evaluate his feelings with a five-point Likert scale. The original version was developed and validated by Watson, Clark and Tellegen in 1988 and it possesses excellent psychometric properties [34].

Visual analogue scales (VAS)

Patients scored their emotional state on a Visual Analogue Scale (VAS), before and after the treatment. In particular, each subject was asked to rate on a range of 0–7 the intensity of its liveliness, sadness, anger, surprise, anxiety, repugnance, fury and serenity at the moment of the administration.

Short flow state scale (short FSS-2)

A short form of Flow State Scale, called Short FSS-2, was completed after treatment to assess the possible state of flow experience [35].

Statistical analysis

Data analysis was conducted with the statistical software Statistical Package for Social Science (SPSS). Given the relatively small sample and the expectation of a non-normal distribution, we opted for the use of non-parametric tests. Differences between the two groups were analyzed with the Mann-Whitney U test, while within analyses were conducted with the Wilcoxon test. The significance level was set to 0,05.

Results

Sample characteristics

The study sample (see Table 1) was composed by 38 participants (23 males and 15 females), with a mean age of 72.66 years old. The mean length of illness was 2.03 years. All subjects had moderately severe chronic airflow limitations with an average FEV1 of 54.26% of the reference value and an average FVC of 72.11%.
Table 1
Comparison of socio-demographic characteristics and baseline parameters of patients in overall sample, study and control groups (p < 0.05)a
Variables
Experimental group
(n = 19)
Control group
(n = 19)
Socio- demographic data
Sex (n, %)
 Female
8 (42.10)
7 (36.80)
 Male
11 (57.90)
12 (63.20)
Age (years) (Mean, SD)
72.53 (10.30)
72.79 (7.06)
Weight (Mean, SD)
72.32 (16.63)
69.59 (13.24)
Height (Mean, SD)
164.32 (8480)
165.26 (10.13)
BMIb (Mean, SD)
26.88 (6.46)
25.5 (4.85)
Educational level (n, %)
 None
1 (5.30)
0 (0)
 Primary School
7 (36.80)
9 (47.40)
 Junior High School
7 (36.80)
6 (31.60)
 High School
4 (21.10)
3 (15.80)
 Graduated or higher education
0 (0)
1 (5.30)
Profession/Job done longer in the past (n, %)
 Housewife
4 (21.10)
2 (10.50)
 Employee
5 (26.30)
2 (10.50)
 Laborer
4 (21.05)
8 (42.10)
 Professional
5 (26.30)
5 (26.30)
 Manager
1 (5.30)
2 (10.50)
Medical and clinical data
Duration of Illness (Mean, SD)
1.79 (0.78)
2.26 (0.80)
 5 (n, %)
8 (42.10)
4 (21.10)
 10 (n, %)
7 (36.80)
6 (31.60)
  > 15 (n, %)
4 (21.10)
9 (47.40)
Smoking (n, %)
 Never
2 (10.50)
0 (0)
 Yes
6 (31.10)
7 (36.80)
 Quitted
11 (57.90)
12 (63.20)
Drugs (n, %)
 LAMA Ib
15 (78.90)
17 (89.50)
 LABA Ib
17 (89.5)
18 (94.70)
 ICSb
12 (63.20)
10 (52.60)
 Anxiolytics
3 (15.80)
9 (47.40)
 Antidepressants
3 (15.80)
4 (21.10)
Exacerbation, last year (n, %)
  < 1
12 (63.20)
10 (52.60)
 1–3
6 (31.60)
9 (47.40)
  > 3
1 (5.30)
0 (0)
Hospitalization, last year (n, %)
  < 1
13 (68.40)
11 (57.90)
 2
5 (26.30)
8 (42.10)
  > 2
1 (5.30)
0 (0)
mMRCc
2.47 (0.51)
2.21 (0.41)
CATc
28.79
30.68
aData are presented as Mean+/-Standard Deviation (SD) and number, percentage (n, %)
bBMI Body Mass Index, LAMA Long-Acting Muscarinic Antagonists, LABA Long-Acting Beta 2-Adrenergic Agonists, ICS Inhaled Corticosteroids
cmMRC Modified Medical Research Council Dyspnoea Scale, CAT COPD Assessment Test

Differences between groups before and after treatment

After the treatment, we found significant differences (Table 2) in favor of the EG in comparison with the CG concerning heart rate (U = 95, z = − 2504, p = 0.006). There were also significant differences between groups about both emotional states, assessed by VAS (U = 108, z = − 2129, p = 0.016), and anxiety state, detected by STAI-Y1 (U = 104.5, z = 2223, p = 0.013).
Table 2
Comparison of psychological characteristics, pulmonary functions and other clinical data between groups at the end of the study (p < 0.05)a
 
Baseline
Post - treatment
Variables
Experimental Group (EG; n = 19)
Control Group (CG; n = 19)
Mann-Whitney Test p (U, Z)
Experimental Group (EG; n = 19)
Control Group (CG; n = 19)
Mann-Whitney Test p (U, Z)
Psychological states
 STAI-Y1b (Mean +/− SD)
33.68 (6.48)
36.68 (10.26)
U = 151.5 z = − 0.848 p = 0.198
26.05 (5.04)
31.26 (7.43)
U = 104.5 z = − 2223 p = 0.013*
PANASb (Mean +/− SD)
  Positive
2.92 (0.24)
3.05 (0.46)
U = 159 z = − 0.633 p = 0.2635
3.17 (0.36)
3.01 (0.38)
U = 139.5 z = − 1202 p = 0.114
  Negative
1.39 (0.48)
1.45 (0.43)
U = 155 z = − 0.751 p = 0.226
1.12 (0.26)
1.12 (0.20)
U = 161 z = − 0.638 p = 0.261
 VASb (Mean +/-SD)
20.53 (5.07)
20.68 (5.45)
U = 173.5 z = − 0.206 p = 0.418
19.79 (3.76)
17.68 (3.95)
U = 108 z = − 2129 p = 0.016*
 FSS-2b (Mean +/-SD)
   
33.63 (3.74)
33.57 (3.06)
U = 174 z = − 0.191 p = 0.424
Psychological traits
 STAI-Y2b (Mean+/− SD)
36.63 (11.96)
39 (11.04)
U = 155 z = − 0.745 p = 0.228
   
Pulmonary functions and physiological data
 FEV1b (Mean +/-SD)
1.35 (0.74)
1.24 (0.51)
U = 175 z = − 0.161 p = 0.436
1.39 (0.75)
1.26 (0.47)
U = 168.5 z = − 0.350 p = 0.363
 FVCb (Mean +/-SD)
2.14 (0.94)
2.27 (0.89)
U = 167 z = − 0.394 p = 0.346
1.97 (0.93)
2.38 (0.81)
U = 127 z = − 1562 p = 0.059
 ROCCb, kPa/l/s (Mean +/-SD)
0.34 (0.14)
0.30 (0.12)
U = 151.5 z = − 0.847 p = 0.198
0.40 (0.19)
0.30 (0.15)
U = 135.5 z = − 1314 p = 0.094
 SpO2b (Mean +/-SD)
91.63 (3.18)
95.58 (2.79)
U = 110.5 z = − 2058 p = 0.020*
93.84 (2.73)
94 (2.62)
U = 175.5 z = − 0.148 p = 0.441
 HRb (Mean+/-SD)
69.32 (8.80)
73.95 (11.47)
U = 140.5 z = − 1171 p = 0.121
65.47 (7.87)
73.05 (11.75)
U = 95 z = − 2504 p = 0.006*
aData are presented as Mean+/-Standard Deviation (SD) and number, percentage (n, %)
bSTAI-Y1 State Trait Anxiety Inventory-State Form, PANAS Positive and Negative Affective Schedule-State Form, VAS Visual Analogue Scale, FSS-2 Short Flow State Scale 2, STAI-Y2 State Trait Anxiety Inventory-Trait Form, FEV1 Forced Expiratory Volume in the First Second, FVC Forced Vital Capacity, ROCC, kPa/l/s Measurement of airway resistance, SpO2 Oxygen saturation, HR Heart Rate

Analysis of the variables within groups before and after treatment

Comparing pre-post intervention (Table 3), the detection of respiratory resistance allowed to detect notable differences only within the experimental group (z = − 1851 p = 0.032). Similarly, the heart rate had an important decrease in the EG (z = − 3576, p = 0.000) and not in the CG (z = − 1776, p = 0.038).
Table 3
Comparison of psychological characteristics, pulmonary functions and other clinical data at baseline and after treatments of patients both in study group and control group (p < 0.05)a
 
Experimental group (EG; n = 19)
Control group (CG; n = 19)
Variables
Baseline
Post - treatment
Wilcoxon Test z, p
Baseline
Post - treatment
Wilcoxon Test z, p
Psychological states
 STAI-Y1b (Mean +/− SD)
33.68 (6.48)
26.05 (5.04)
z = − 3771 p = 0.000*
36.68 (10.26)
31.26 (7.43)
z = − 3010 p = 0.001*
PANASb (Mean +/− SD)
  Positive
2926 (0.24)
3.17 (0.36)
z = − 2581 p = 0.005*
3.05 (0.46)
3.01 (0.38)
z = − 0.88 p = 0.465
  Negative
1395 (0.48)
1.12 (0.26)
z = − 3127 p = 0.001*
1.45 (0.43)
1.12 (0.20)
z = − 3186 p = 0.000*
 VASb (Mean +/-SD)
20.53 (5.07)
19.79 (3.76)
z = − 0.284 p = 0.388
20.68 (5.45)
17.68 (3.95)
z = − 2605 p = 0.004*
Psychological traits
 STAI-Y2b (Mean+/− SD)
36.63 (11.96)
  
39 (11.04)
  
Pulmonary functions and physiological data
 FEV1b (Mean +/-SD)
1.35 (0.74)
1.39 (0.75)
z = − 0.735 p = 0.231
1.24 (0.51)
1.26 (0.47)
z = − 1702 p = 0.044*
 FVCb (Mean +/-SD)
2143 (0.94)
1.97 (0.93)
z = − 2378 p = 0.008*
2.27 (0.89)
2.38 (0.81)
z = − 2335 p = 0.010*
 ROCCb, kPa/l/s (Mean +/-SD)
0.34 (0.14)
0.40 (0.19)
z = − 1851 p = 0.032*
0.30 (0.12)
0.30 (0.15)
z = − 0.362 p = 0.358
 vSpO2b (Mean +/-SD)
91.63 (3.18)
93.84 (2.73)
z = − 2672 p = 0.004*
95.58 (2.79)
94 (2.62)
z = − 1327 p = 0.092
 HRb (Mean+/-SD)
69.32 (8.80)
65.47 (7.87)
z =  3576 p = 0.000*
73.95 (11.47)
73.05 (11.75)
z = − 1776 p = 0.038*
aData are presented as Mean+/-Standard Deviation (SD) and number, percentage (n, %)
bSTAI-Y1 State Trait Anxiety Inventory-State Form, PANAS Positive and Negative Affective Schedule-State Form, VAS Visual Analogue Scale, FSS-2 Short Flow State Scale 2, STAI-Y2 State Trait Anxiety Inventory-Trait Form, FEV1 Forced Expiratory Volume in the First Second, FVC Forced Vital Capacity, ROCC, kPa/l/s Measurement of airway resistance, SpO2 Oxygen saturation, HR Heart Rate
Regarding the psychological states, there was a significant change about the positive affects only within the experimental group (z = − 2581, p = 0.005); while there was a significance change about the negative affections in both groups (experimental group: z = − 3127, p = 0.001; control group: z = − 3186, p = 0.000).

Discussion

We conducted a Randomized Control Trial to evaluate the impact of a relaxation technique on psychological and physiological well-being of people with COPD. The findings of this study suggest that a brief relaxation technique, based on mindful natural breathing, can be a helpful tool to improve psychological well-being and symptoms management of people with COPD. In particular, this mindful natural breathing improved the blood oxygenation load and FVC, as well as breathing resistance. That means, that respiratory levels improved after an 11-min guided relaxation training. This result supports the hypothesis that relaxation techniques can promote better blood oxygenation, in line with previous studies [23, 36]. It is also reported a significant decrease in heart rate: this other data corroborates the results of previous works on relaxation techniques that have found a decrease in heart beats per minute [37].
The relaxation audio had a positive emotional effect, increasing positive affects and reducing negative affections, confirming the hypothesis and previously obtained results [37, 38]. Furthermore, anxiety was significantly reduced after the intervention, both in comparison with the baseline assessment and with the control group. This confirms the idea that relaxation is one of the main treatments for anxiety [39, 40].
Study results could be useful in the clinical practice and highly reproducible. The intervention was held in a single session and with the use of an audio-recorded relaxing track. Furthermore, this type of quick relaxation exercise could be useful during daytime activities of people with COPD, especially when they are alone or when anxiety emerges as a possible attack of dyspnea. Relaxation techniques can, in fact, be practiced at any time, even on their own. Furthermore, relaxation techniques can be incorporated into other interventions, helping to reduce anxiety and depression. Therefore, the inclusion of relaxation training in the clinical routine of pulmonary services with COPD could be easily accomplished and could provide positive effects. In fact, even if our study was limited by a single session of the intervention, it was able to alleviate anxiety and improve well-being, with a highly scalable approach. Nevertheless, it is also limited by its relatively small sample size. Furthermore, generalization of the results from this study is restricted by the participants’ characteristics, who represented a narrow range of education levels, with basically no subjects with a graduate degree. The study was conducted in single-blind mode, therefore the researcher was aware of the group of the subject. Even if self-report and physiological assessments may be less influenced than other instruments, we recognize that limitation. Furthermore, it is possible to note that the main differences between groups are limited to the anxiety state and the dyspnea perceived as well as the heart rate, confirming that they are intrinsically related: indeed, sympathetic arousal is a physiological manifestation of anxiety. This result could also suggest the importance to improve the patient’s education in practicing the technique in order to obtain more significant short-term effects. Finally, the study was conducted in the hospital, during regular exams, and therefore it is not generalizable outside this setting.
Future works may consider a larger and more representative sample, with assessments from multiple settings. Nonetheless, further studies are needed to investigate better the efficacy and effectiveness of a relaxation technique based on mindful natural breathing, taking advantages of more than one session, because a long-term practice could boost beyond the benefits.
Motivation and concentration are essential in the practice of relaxation. These two elements require a certain level of patients’ engagement, that can be stimulated by health practitioners. Our findings indicate that relaxation techniques could pay an important role in intervention strategies, contributing to an improvement of the QoL and the well-being of people with COPD. The possible impact of this use of relaxation training on health costs may deserve a future investigation.

Conclusions

The findings of our study show that a relaxation technique based on mindful natural breathing might have a potential to improve the COPD patients’ overall well-being. In particular, mindful natural breathing induces significant improvements in respiratory and cardiac functions, together with a positive emotional effect and a reduction of anxiety. Although the present study is a short-term one and its conclusions must be confirmed by further studies, it was required before a long-term investigation, in order to examine the endurance and the utility of the treatment to the patients.

Acknowledgements

The abstract of this paper was presented at the International Conference on Studies in Humanities and Social Science (SHSS-2015), ERPUB 2015, Paris (France) as a conference talk with interim findings. The poster’s abstract was published in “Poster Abstracts” in International Conference on Studies in Humanities and Social Sciences (SHSS-2015) (pp. 317-425). Plaisent Michel; Zheng Lili.
The study was approved by the Comitato Etico Centrale IRCCS Regione Lombardia, at IRCCS Santa Maria Nascente, Fondazione Don Carlo Gnocchi, Milan (Italy) (Ethical Committee) on 15th October 2013.

Funding

No funding was provided for this study.

Availability of data and materials

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
Each participant was informed about the study details and procedure and receive both a leaflet about the study and an institutional Consent Form. There were also the contacts of the investigators to ask for more information if they wished. Participants who consented to take part to the study, had the opportunity to ask for further information and to discuss and consent for participation in a face to face meeting with the investigator.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
Literatur
1.
Zurück zum Zitat GOLD. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2016 [Internet]. 2016. Available from: http://goldcopd.org. GOLD. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2016 [Internet]. 2016. Available from: http://​goldcopd.​org.
2.
Zurück zum Zitat Fabbri LM, Hurd SS. GOLD scientific committee. Global strategy for the diagnosis, management and prevention of COPD: 2003 update. Eur Respir J. 2003;22(1):1–2.CrossRefPubMed Fabbri LM, Hurd SS. GOLD scientific committee. Global strategy for the diagnosis, management and prevention of COPD: 2003 update. Eur Respir J. 2003;22(1):1–2.CrossRefPubMed
3.
Zurück zum Zitat Arne M, Emtner M, Janson S, Wilde-Larsson B. COPD patients perspectives at the time of diagnosis: a qualitative study. Prim Care Respir J J Gen Pract Airw Group. 2007;16(4):215–21. Arne M, Emtner M, Janson S, Wilde-Larsson B. COPD patients perspectives at the time of diagnosis: a qualitative study. Prim Care Respir J J Gen Pract Airw Group. 2007;16(4):215–21.
4.
Zurück zum Zitat Wong CJ, Goodridge D, Marciniuk DD, Rennie D. Fatigue in patients with COPD participating in a pulmonary rehabilitation program. Int J Chron Obstruct Pulmon Dis. 2010;5:319–26.CrossRefPubMedPubMedCentral Wong CJ, Goodridge D, Marciniuk DD, Rennie D. Fatigue in patients with COPD participating in a pulmonary rehabilitation program. Int J Chron Obstruct Pulmon Dis. 2010;5:319–26.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet Lond Engl. 1997;349(9064):1498–504.CrossRef Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet Lond Engl. 1997;349(9064):1498–504.CrossRef
6.
Zurück zum Zitat Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14(6):540–5.CrossRefPubMed Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14(6):540–5.CrossRefPubMed
7.
Zurück zum Zitat Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. GOLD scientific committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary. Am J Respir Crit Care Med. 2001;163(5):1256–76.CrossRefPubMed Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. GOLD scientific committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary. Am J Respir Crit Care Med. 2001;163(5):1256–76.CrossRefPubMed
8.
Zurück zum Zitat Burney PGJ, Patel J, Newson R, Minelli C, Naghavi M. Global and regional trends in COPD mortality, 1990-2010. Eur Respir J. 2015;45(5):1239–47.CrossRefPubMedPubMedCentral Burney PGJ, Patel J, Newson R, Minelli C, Naghavi M. Global and regional trends in COPD mortality, 1990-2010. Eur Respir J. 2015;45(5):1239–47.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Berry MJ, Rejeski WJ, Adair NE, Zaccaro D. Exercise rehabilitation and chronic obstructive pulmonary disease stage. Am J Respir Crit Care Med. 1999;160(4):1248–53.CrossRefPubMed Berry MJ, Rejeski WJ, Adair NE, Zaccaro D. Exercise rehabilitation and chronic obstructive pulmonary disease stage. Am J Respir Crit Care Med. 1999;160(4):1248–53.CrossRefPubMed
10.
Zurück zum Zitat Lacasse Y, Brosseau L, Milne S, Martin S, Wong E, Guyatt GH, et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2002;(3):CD003793. Lacasse Y, Brosseau L, Milne S, Martin S, Wong E, Guyatt GH, et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2002;(3):CD003793.
11.
Zurück zum Zitat Lacasse Y, Goldstein R, Lasserson TJ, Martin S. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2006;4:CD003793. Lacasse Y, Goldstein R, Lasserson TJ, Martin S. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2006;4:CD003793.
12.
Zurück zum Zitat Ries AL, Bauldoff GS, Carlin BW, Casaburi R, Emery CF, Mahler DA, et al. Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based clinical practice guidelines. Chest. 2007;131(5 Suppl):4S–42S.CrossRefPubMed Ries AL, Bauldoff GS, Carlin BW, Casaburi R, Emery CF, Mahler DA, et al. Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based clinical practice guidelines. Chest. 2007;131(5 Suppl):4S–42S.CrossRefPubMed
13.
Zurück zum Zitat Wagena EJ, Arrindell WA, Wouters EFM, van Schayck CP. Are patients with COPD psychologically distressed? Eur Respir J. 2005;26(2):242–8.CrossRefPubMed Wagena EJ, Arrindell WA, Wouters EFM, van Schayck CP. Are patients with COPD psychologically distressed? Eur Respir J. 2005;26(2):242–8.CrossRefPubMed
14.
Zurück zum Zitat Kunik ME, Roundy K, Veazey C, Souchek J, Richardson P, Wray NP, et al. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest. 2005;127(4):1205–11.PubMed Kunik ME, Roundy K, Veazey C, Souchek J, Richardson P, Wray NP, et al. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest. 2005;127(4):1205–11.PubMed
15.
Zurück zum Zitat van den Boom G, van Schayck CP, van Möllen MP, Tirimanna PR, den Otter JJ, van Grunsven PM, et al. Active detection of chronic obstructive pulmonary disease and asthma in the general population. Results and economic consequences of the DIMCA program. Am J Respir Crit Care Med. 1998;158(6):1730–8.CrossRefPubMed van den Boom G, van Schayck CP, van Möllen MP, Tirimanna PR, den Otter JJ, van Grunsven PM, et al. Active detection of chronic obstructive pulmonary disease and asthma in the general population. Results and economic consequences of the DIMCA program. Am J Respir Crit Care Med. 1998;158(6):1730–8.CrossRefPubMed
16.
Zurück zum Zitat Kim HFS, Kunik ME, Molinari VA, Hillman SL, Lalani S, Orengo CA, et al. Functional impairment in COPD patients: the impact of anxiety and depression. Psychosomatics. 2000;41(6):465–71.CrossRefPubMed Kim HFS, Kunik ME, Molinari VA, Hillman SL, Lalani S, Orengo CA, et al. Functional impairment in COPD patients: the impact of anxiety and depression. Psychosomatics. 2000;41(6):465–71.CrossRefPubMed
17.
Zurück zum Zitat Yohannes AM. Predictors of 1-year mortality in patients discharged from hospital following acute exacerbation of chronic obstructive pulmonary disease. Age Ageing. 2005;34(5):491–6.CrossRefPubMed Yohannes AM. Predictors of 1-year mortality in patients discharged from hospital following acute exacerbation of chronic obstructive pulmonary disease. Age Ageing. 2005;34(5):491–6.CrossRefPubMed
18.
Zurück zum Zitat Bosley CM, Corden ZM, Rees PJ, Cochrane GM. Psychological factors associated with use of home nebulized therapy for COPD. Eur Respir J. 1996;9(11):2346–50.CrossRefPubMed Bosley CM, Corden ZM, Rees PJ, Cochrane GM. Psychological factors associated with use of home nebulized therapy for COPD. Eur Respir J. 1996;9(11):2346–50.CrossRefPubMed
19.
Zurück zum Zitat Gudmundsson G, Gislason T, Janson C, Lindberg E, Suppli Ulrik C, Brøndum E, et al. Depression, anxiety and health status after hospitalisation for COPD: a multicentre study in the Nordic countries. Respir Med. 2006;100(1):87–93.CrossRefPubMed Gudmundsson G, Gislason T, Janson C, Lindberg E, Suppli Ulrik C, Brøndum E, et al. Depression, anxiety and health status after hospitalisation for COPD: a multicentre study in the Nordic countries. Respir Med. 2006;100(1):87–93.CrossRefPubMed
21.
Zurück zum Zitat Pagnini F, Manzoni GM, Castelnuovo G, Molinari E. The efficacy of relaxation training in treating anxiety. Int J Behav Consult Ther. 2010;5(3–4):264–9. Pagnini F, Manzoni GM, Castelnuovo G, Molinari E. The efficacy of relaxation training in treating anxiety. Int J Behav Consult Ther. 2010;5(3–4):264–9.
22.
Zurück zum Zitat Volpato E, Banfi P, Rogers SM, Pagnini F. Relaxation techniques for people with chronic obstructive pulmonary disease: a systematic review and a meta-analysis. Evid Based Complement Alternat Med. 2015;2015:1–22.CrossRef Volpato E, Banfi P, Rogers SM, Pagnini F. Relaxation techniques for people with chronic obstructive pulmonary disease: a systematic review and a meta-analysis. Evid Based Complement Alternat Med. 2015;2015:1–22.CrossRef
23.
Zurück zum Zitat SW-S L. The effects of guided imagery relaxation in people with COPD. Occup Ther Int. 2004;11(3):145–59.CrossRef SW-S L. The effects of guided imagery relaxation in people with COPD. Occup Ther Int. 2004;11(3):145–59.CrossRef
24.
Zurück zum Zitat Moody LE, Fraser M, Yarandi H. Effects of guided imagery in patients with chronic bronchitis and emphysema. Clin Nurs Res. 1993;2(4):478–86.CrossRefPubMed Moody LE, Fraser M, Yarandi H. Effects of guided imagery in patients with chronic bronchitis and emphysema. Clin Nurs Res. 1993;2(4):478–86.CrossRefPubMed
25.
Zurück zum Zitat Emery CF, Leatherman NE, Burker EJ, McIntre NR. Psychological outcomes of a pulmonary rehabilitation program. Chest. 1991;100(3):613–7. Emery CF, Leatherman NE, Burker EJ, McIntre NR. Psychological outcomes of a pulmonary rehabilitation program. Chest. 1991;100(3):613–7.
26.
Zurück zum Zitat Garuti G, Cilione C, Dell’Orso D, Gorini P, Lorenzi MC, Totaro L, et al. Impact of comprehensive pulmonary rehabilitation on anxiety and depression in hospitalized COPD patients. Monaldi Arch Chest Dis. 2003;59(1):56–61. Garuti G, Cilione C, Dell’Orso D, Gorini P, Lorenzi MC, Totaro L, et al. Impact of comprehensive pulmonary rehabilitation on anxiety and depression in hospitalized COPD patients. Monaldi Arch Chest Dis. 2003;59(1):56–61.
27.
Zurück zum Zitat Lolak S, Connors GL, Sheridan MJ, Wise TN. Effects of progressive muscle relaxation training on anxiety and depression in patients enrolled in an outpatient pulmonary rehabilitation program. Psychother Psychosom. 2008;77(2):119–25.CrossRefPubMed Lolak S, Connors GL, Sheridan MJ, Wise TN. Effects of progressive muscle relaxation training on anxiety and depression in patients enrolled in an outpatient pulmonary rehabilitation program. Psychother Psychosom. 2008;77(2):119–25.CrossRefPubMed
28.
Zurück zum Zitat Ries AL, Kaplan RM, Limberg TM, Prewitt LM. Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease. Ann Intern Med. 1995;122(11):823–32. Ries AL, Kaplan RM, Limberg TM, Prewitt LM. Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease. Ann Intern Med. 1995;122(11):823–32.
29.
Zurück zum Zitat Cahalin LP, Braga M, Matsuo Y, Hernandez ED. Efficacy of diaphragmatic breathing in persons with chronic obstructive pulmonary disease: a review of the literature. J Cardiopulm Rehabil. 2002;22(1):7–21. Cahalin LP, Braga M, Matsuo Y, Hernandez ED. Efficacy of diaphragmatic breathing in persons with chronic obstructive pulmonary disease: a review of the literature. J Cardiopulm Rehabil. 2002;22(1):7–21.
30.
Zurück zum Zitat Payne RA, Donaghy M, Payne RA, Editors. Payne’s handbook of relaxation techniques: a practical guide for the health care professional. 4th ed. Edinburgh; New York: Churchill Livingstone/Elsevier; 2010. 274 pe. Payne RA, Donaghy M, Payne RA, Editors. Payne’s handbook of relaxation techniques: a practical guide for the health care professional. 4th ed. Edinburgh; New York: Churchill Livingstone/Elsevier; 2010. 274 pe.
31.
Zurück zum Zitat Benson HMD, Klipper MZ. The relaxation response. New York: Harper Collins; 1992. Benson HMD, Klipper MZ. The relaxation response. New York: Harper Collins; 1992.
32.
Zurück zum Zitat Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–38.CrossRefPubMed Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–38.CrossRefPubMed
33.
Zurück zum Zitat Spielberger CD, Gorsuch RL, Lushene RE, Vagg PR. State-trait anxiety inventory (STAI). BiB. 2010;180:1970. Spielberger CD, Gorsuch RL, Lushene RE, Vagg PR. State-trait anxiety inventory (STAI). BiB. 2010;180:1970.
34.
Zurück zum Zitat Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988;54(6):1063–70.CrossRefPubMed Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988;54(6):1063–70.CrossRefPubMed
35.
Zurück zum Zitat Jackson SA, Martin AJ, Eklund RC. Long and short measures of flow: the construct validity of the FSS-2, DFS-2, and new brief counterparts. J Sport Exerc Psychol. 2008;30(5):561–87.CrossRefPubMed Jackson SA, Martin AJ, Eklund RC. Long and short measures of flow: the construct validity of the FSS-2, DFS-2, and new brief counterparts. J Sport Exerc Psychol. 2008;30(5):561–87.CrossRefPubMed
36.
Zurück zum Zitat Wu H-S, Lin L-C, Wu S-C, Lin J-G. The psychologic consequences of chronic dyspnea in chronic pulmonary obstruction disease: the effects of acupressure on depression. J Altern Complement Med N Y N. 2007;13(2):253–61.CrossRef Wu H-S, Lin L-C, Wu S-C, Lin J-G. The psychologic consequences of chronic dyspnea in chronic pulmonary obstruction disease: the effects of acupressure on depression. J Altern Complement Med N Y N. 2007;13(2):253–61.CrossRef
37.
Zurück zum Zitat Davison GC, Williams ME, Nezami E, Bice TL, DeQuattro VL. Relaxation, reduction in angry articulated thoughts, and improvements in borderline hypertension and heart rate. J Behav Med. 1991;14(5):453–68.CrossRefPubMed Davison GC, Williams ME, Nezami E, Bice TL, DeQuattro VL. Relaxation, reduction in angry articulated thoughts, and improvements in borderline hypertension and heart rate. J Behav Med. 1991;14(5):453–68.CrossRefPubMed
38.
Zurück zum Zitat von Leupoldt A, Taube K, Schubert-Heukeshoven S, Magnussen H, Dahme B. Distractive auditory stimuli reduce the unpleasantness of dyspnea during exercise in patients with COPD. Chest. 2007;132(5):1506–12.CrossRefPubMed von Leupoldt A, Taube K, Schubert-Heukeshoven S, Magnussen H, Dahme B. Distractive auditory stimuli reduce the unpleasantness of dyspnea during exercise in patients with COPD. Chest. 2007;132(5):1506–12.CrossRefPubMed
39.
Zurück zum Zitat Gift AG, Moore T, Soeken K. Relaxation to reduce dyspnea and anxiety in COPD patients. Nurs Res. 1992;41(4):242–6.CrossRefPubMed Gift AG, Moore T, Soeken K. Relaxation to reduce dyspnea and anxiety in COPD patients. Nurs Res. 1992;41(4):242–6.CrossRefPubMed
40.
Zurück zum Zitat Santana MJ, S-Parrilla J, Mirus J, Loadman M, Lien DC, Feeny D. An assessment of the effects of Iyengar yoga practice on the health-related quality of life of patients with chronic respiratory diseases: a pilot study. Can Respir J. 2013;20(2):e17–23.CrossRefPubMedPubMedCentral Santana MJ, S-Parrilla J, Mirus J, Loadman M, Lien DC, Feeny D. An assessment of the effects of Iyengar yoga practice on the health-related quality of life of patients with chronic respiratory diseases: a pilot study. Can Respir J. 2013;20(2):e17–23.CrossRefPubMedPubMedCentral
Metadaten
Titel
A quick relaxation exercise for people with chronic obstructive pulmonary disease: explorative randomized controlled trial
verfasst von
Eleonora Volpato
Paolo Banfi
Antonello Nicolini
Francesco Pagnini
Publikationsdatum
01.12.2018
Verlag
BioMed Central
Erschienen in
Multidisciplinary Respiratory Medicine / Ausgabe 1/2018
Elektronische ISSN: 2049-6958
DOI
https://doi.org/10.1186/s40248-018-0124-9

Weitere Artikel der Ausgabe 1/2018

Multidisciplinary Respiratory Medicine 1/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.